Stocktipster

$DDI gets taken out at $16.25 cash through a tender. 95% of shares must be tendered for the deal to go through. Can go lower, 90%. Double U owns 67.05% of co Hold outs will get acquired through a 2nd step under Korean Commercial Act

$SGRY “amended its take-private deal with HealthSpan Partners, with the acquisition price raised to $25 a share as company rejects a higher competing offer over concerns about regulatory risks and timing of potential closing” Third party offered $28 cash Bidding war incoming?

Are we getting obliterated? $SPY $QQQ

$PERI to be acquired by Affle 3i for $11.70 cash 40 days go shop period expiring December 11 No financing condition. $C is funding the deal Closing 1Q27 Israeli company. Check how taxes may impact you

$KPTI RIP

$ADT to be acquired by Thrive capital for $10 cash. Funded by former owner Apollo Go shop period 30 days. Don’t bank one this Closing 1Q2027

Trían offers $7.35 cash to take $WEN private Hopefully management understands this is it

$ULBI agrees to be taken over by $ENS for $16 cash. Closing 1Q2027 Tender offer structure. Some overlap may exist in military batteries here. Ultralife Chinese operations could draw some regulatory concern

$MFIC merging with $ARCC for ~$10.88 $1.21 cash + $9.67 in ares’ stock Stock portion to be adjusted down as Midcap expects to distribute a special dividend (all undistributed taxable income estimated to remain as of closing of the Transaction) midcap est its nav at $12.86

$SGRY to be taken private by HealthSpan Partners for $23.50 cash Bain, owns 39% of co, rolls over its stake Closing 1Q2027 Watch out for overlaps could run into delays if regulators play hard ball It’s health!

$QGEN getting acquired by EQT for $52.06. I remember back in 2020/1 when they rejected an offer arguing offer was undervaluing the company. Years ahead price is basically the same. Another fun fact this merger has an adverse market change. +25% drawdown deal is off Signs ?

$CRM buying $BRZE for $47.50 cash Closing in CRM’s fiscal 2028 Needs several regulatory approvals hence the long timeframe Worth keeping an eye on but not jumping rn

Monday merger ! $SLN to be acquired by Merck (Germany) for $20 cash Closing 1Q27 130% premium ! Buying some. Spread is decent Shouldn’t run into regulatory issues

$VRNS getting a cash offer for $49.75 Closing 1H27 Buyer Proofpoint Spread is not that good as has been the case for the past months Interesting to watch on the sidelines

$PCRX bought out by $VTRS for $36.5 cash. Closing end of 2026 Tender offer No financing condition

$OPCH to be acquired by CD&R and McKesson for $32.05 in cash Closing 1H2027

$PTC to be bought by Schneider for $205 cash Deal closing 3Q27 Funding mostly through debt Will monitor this one Long time to close means lots of regulatory approvals.

How have most consumer stocks plunged lately but $SPHR has held on so well?